A carregar...
20 µg versus >20 µg estrogen combined oral contraceptives for contraception
BACKGROUND: Concern about estrogen‐related adverse effects has led to progressive reductions in the estrogen dose in combination oral contraceptives (COCs). However, reducing the amount of estrogen to improve safety could result in decreased contraceptive effectiveness and unacceptable changes in bl...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2013
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7173696/ https://ncbi.nlm.nih.gov/pubmed/23904209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003989.pub5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|